Lazard Asset Management LLC Novo Nordisk A S Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,313,423 shares of NVO stock, worth $142 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,313,423

Previous 1,155,500 13.67%

Holding current value

$142 Million

Previous $165 Million 5.18%

% of portfolio

0.23%

Previous 0.23%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $18.8 Million - $23 Million	157,923 Added 13.67%	1,313,423 $156 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $10.1 Million - $12.1 Million	-82,386 Reduced 6.66%	1,155,500 $165 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $22.6 Million - $30.1 Million	-221,308 Reduced 15.17%	1,237,886 $159 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $3.07 Million - $3.69 Million	-35,020 Reduced 2.34%	1,459,194 $151 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $87.7 Million - $192 Million	964,640 Added 182.15%	1,494,214 $136 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $81.8 Million - $90.5 Million	524,139 Added 9643.77%	529,574 $85.7 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $19,453 - $23,393	147 Added 2.78%	5,435 $864,000
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $91,064 - $120,173	-888 Reduced 14.38%	5,288 $715,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $586,353 - $719,587	6,154 Added 27972.73%	6,176 $615,000
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $2,271 - $2,679	22 New	22 $2,000
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $163,192 - $178,827	-3,490 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $23,695 - $26,974	-535 Reduced 13.29%	3,490 $160,000
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $2,909 - $3,488	-60 Reduced 1.47%	4,025 $198,000
Q4 2017 Aug 28, 2019	BUY	$47.53 - $53.73 $2,851 - $3,223	60 Added 1.49%	4,085 $219,000
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $2,851 - $3,223	-60 Reduced 1.47%	4,025 $216,000
Q3 2017 Aug 19, 2019	BUY	$41.15 - $49.22 $2,469 - $2,953	60 Added 1.49%	4,085 $196,000
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $8.42 Million - $10.1 Million	-204,587 Reduced 98.07%	4,025 $193,000
Q2 2017 Aug 19, 2019	SELL	N/A	-2,190 Reduced 1.04%	208,612 $8.95 Million
Q1 2017 Aug 13, 2019	BUY	N/A	2,453 Added 1.18%	210,802 $7.23 Million
Q4 2016 Jul 30, 2019	SELL	N/A	-100,870 Reduced 32.62%	208,349 $7.47 Million
Q3 2016 Aug 07, 2019	SELL	N/A	-1,585,708 Reduced 83.68%	309,219 $12.9 Million
Q2 2016 Jul 29, 2019	BUY	N/A	34,447 Added 1.85%	1,894,927 $102 Million
Q1 2016 Jul 25, 2019	BUY	N/A	110,759 Added 6.33%	1,860,480 $101 Million
Q4 2015 Jul 24, 2019	SELL	N/A	-390,874 Reduced 18.26%	1,749,721 $102 Million
Q3 2015 Jul 15, 2019	BUY	N/A	60,529 Added 2.91%	2,140,595 $116 Million
Q2 2015 Jul 08, 2019	BUY	N/A	62,732 Added 3.11%	2,080,066 $114 Million
Q4 2014 Aug 29, 2019	BUY	N/A	2,017,334	2,017,334 $85.4 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Novo Nordisk A S Transaction History